A recent study reported promoter methylation profiles of hMLH1, MGMT and CDKN2A in 51 cases of HNSCCs using MSP and demonstrated that tumours with two or more methylated genes had improved DFS at 2 years (Puri et al, 2005). Here, MGMT is linked to neoplasm.